TransCode Therapeutics Inc’s Shares Reel: -28.19% Quarterly Revenue Decline Amid 3.45M Market Cap
The market performance of TransCode Therapeutics Inc’s stock has been turbulent in recent times. Over the last year, the company’s stock reached its highest point at $356.00 on 04/27/23, while the lowest value for the same duration was $0.42 on 04/24/24. 52-week price history of